HRTX

Heron Therapeutics (HRTX)

About Heron Therapeutics (HRTX)

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.

Details

Daily high

$1.94

Daily low

$1.85

Price at open

$1.90

52 Week High

$3.93

52 Week Low

$1.04

Market cap

292.9M

Dividend yield

0.00%

Volume

280,058

Avg. volume

2.2M

P/E ratio

-34.91

Heron Therapeutics News